Besides, baseline characteristics including age, sex and Eastern Cooperative Oncology Group (ECOG) score are the candidate factors to explore and subgroup analyses of squamous cancer, smoking status, EGFR mutation (within NSCLC patients) and BRAF mutation (within melanoma patients) are also conducted to provide further evidence for clinical treatment. Here, BRAF is linked to melanoma.